Literature DB >> 24484736

Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection.

Derek L Clouthier1, Tania H Watts2.   

Abstract

A breadth of studies have demonstrated the importance of GITR-GITRL in diverse immune processes. However, only a limited number of studies to date have attributed the effects of GITR/GITRL to specific cell types. Moreover, the context-dependent role of GITR/GITRL in different models makes the consequences of GITR ligation difficult to generalize. There is a significant interest in the therapeutic application of GITR agonists and antagonists in human disease. Thus, the field must come to a consensus regarding the cell type-specific and physiological effects of GITR in different disease states. Here we attempt to summarize the extensive literature on GITR, to synthesize a more cohesive picture of the role of GITR/GITRL in immunity, and to identify areas that require clarification.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Co-stimulation; GITR; GITRL; T cell; TNFR

Mesh:

Substances:

Year:  2014        PMID: 24484736     DOI: 10.1016/j.cytogfr.2013.12.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  24 in total

Review 1.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

Review 2.  ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.

Authors:  Klaus Ley; Norbert Gerdes; Holger Winkels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-30       Impact factor: 8.311

3.  Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.

Authors:  Stephanie Dorta-Estremera; Renee L Chin; Gloria Sierra; Courtney Nicholas; Ananta V Yanamandra; Sita M K Nookala; Guojun Yang; Shail Singh; Michael A Curran; K Jagannadha Sastry
Journal:  Cancer Res       Date:  2018-07-27       Impact factor: 12.701

Review 4.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

5.  Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.

Authors:  Mayanne M T Zhu; Samantha Burugu; Dongxia Gao; Jamie Yu; Zuzana Kos; Samuel Leung; Basil A Horst; Torsten O Nielsen
Journal:  Mod Pathol       Date:  2020-04-29       Impact factor: 7.842

6.  Sectm1a Facilitates Protection against Inflammation-Induced Organ Damage through Promoting TRM Self-Renewal.

Authors:  Xingjiang Mu; Hongkuan Fan; Peng Wang; Yutian Li; Karen Domenico; Qianqian Li; Xiaohong Wang; Kobina Essandoh; Jing Chen; Tianqing Peng; Guo-Chang Fan
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

Review 7.  Fish TNF and TNF receptors.

Authors:  Yaoguo Li; Tiaoyi Xiao; Jun Zou
Journal:  Sci China Life Sci       Date:  2020-07-24       Impact factor: 6.038

8.  Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors.

Authors:  Kyriakos P Papadopoulos; Karen Autio; Talia Golan; Konstantin Dobrenkov; Elliot Chartash; Qiusheng Chen; Richard Wnek; Georgina V Long
Journal:  Clin Cancer Res       Date:  2020-12-21       Impact factor: 13.801

9.  Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.

Authors:  Maria Fernanda Pascutti; Sulima Geerman; Edith Slot; Klaas P J M van Gisbergen; Louis Boon; Ramon Arens; Rene A W van Lier; Monika C Wolkers; Martijn A Nolte
Journal:  PLoS Pathog       Date:  2015-03-04       Impact factor: 6.823

Review 10.  Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.

Authors:  Simona Ronchetti; Erika Ricci; Maria Grazia Petrillo; Luigi Cari; Graziella Migliorati; Giuseppe Nocentini; Carlo Riccardi
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.